Ali Asif — SEC Form 4 filings
SEC reporting owner CIK 1921163. 13 Form 4 filings on record with FilingPulse; latest filed 2026-04-21.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-18 to 2026-04-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 10 filings — 151,507 shares, $10,286,004 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 24,765 shares @ $104.24 ($2,581,504) in Protagonist Therapeutics, Inc, filed 2026-03-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 13 | — | 16 legs · 151,507 sh · $10,286,004 | 23 |
Form 4 filings — Ali Asif
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,750 @ $105.47 | EDGAR |
| 2026-03-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 19,500 @ $19.19 · Option exercise (M): 5,265 @ $12.17 · Sale (S): 24,765 @ $104.24 · Option exercise (M): 19,500 (derivative) @ $0 · Option exercise (M): 5,265 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 16,000 @ $19.19 · Option exercise (M): 12,000 @ $12.17 · Sale (S): 28,000 @ $83.13 · Sale (S): 18,203 @ $83.14 · Option exercise (M): 16,000 (derivative) @ $0 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 8,588 @ $82.48 | EDGAR |
| 2026-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 25,600 @ $0 · Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,756 @ $46 | EDGAR |
| 2025-03-14 | 4 | Protagonist Therapeutics, Inc (PTGX) | Option exercise (M): 15,203 @ $12.17 · Option exercise (M): 9,700 @ $19.19 · Sale (S): 24,903 @ $58.73 · Option exercise (M): 15,203 (derivative) @ $0 · Option exercise (M): 9,700 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,317 @ $0 · Sale (S): 2,601 @ $0 | EDGAR |
| 2025-01-06 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 31,779 @ $0 · Grant/award (A): 38,520 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 2,203 @ $44.59 · Option exercise (M): 6,000 @ $19.19 · Option exercise (M): 6,000 @ $12.17 · Sale (S): 12,000 @ $44.47 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 1,234 @ $25.11 | EDGAR |
| 2024-03-01 | 4 | Protagonist Therapeutics, Inc (PTGX) | Sale (S): 7,850 @ $30.61 · Sale (S): 2,089 @ $31 · Option exercise (M): 12,000 @ $12.17 · Sale (S): 12,000 @ $32.22 · Sale (S): 2,248 @ $32.33 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | Protagonist Therapeutics, Inc (PTGX) | Tax withholding (F): 1,452 @ $24.63 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1921163 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →